PortfoliosLab logoPortfoliosLab logo
ISIN
US68247Q1022
CUSIP
68247Q102
IPO Date
Sep 12, 2018

Highlights

Market Cap
$32.54M
Enterprise Value
$36.73M
EPS (TTM)
-CN¥8.64
Total Revenue (TTM)
CN¥11.35B
Gross Profit (TTM)
CN¥651.99M
EBITDA (TTM)
-CN¥18.04M
Year Range
$2.48 - $11.17
ROA (TTM)
-26.90%
ROE (TTM)
70.44%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


111, Inc.

Performance

YI Performance Chart

111, Inc. (YI) is up 44.5% since the beginning of the year. At $4 per share, YI is trading 66.9% below its 52-week high of $11. Investors who bought $1,000 worth of YI shares 5 years ago would now be looking at an investment worth $42.


Loading charts...

S&P 500 Index

Returns By Period

111, Inc. (YI) has returned 44.53% so far this year and -53.75% over the past 12 months.


111, Inc.

1D
-16.10%
1M
-35.09%
YTD
44.53%
6M
16.72%
1Y
-53.75%
3Y*
-47.38%
5Y*
-46.92%
10Y*

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

YI Monthly Returns History

Based on dividend-adjusted daily data since Sep 12, 2018, YI's average daily return is -0.04%, while the average monthly return is -0.93%.

Historically, 37% of months were positive and 63% were negative. The best month was Jan 2026 with a return of +185.2%, while the worst month was Dec 2018 at -35.4%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, YI closed higher 44% of trading days. The best single day was Sep 10, 2019 with a return of +62.0%, while the worst single day was Dec 4, 2018 at -25.0%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026185.16%8.36%-17.57%-4.91%-14.84%-29.92%44.53%
2025-6.58%52.41%-8.57%1.97%-1.21%-12.60%-3.79%-6.40%-29.24%-3.96%-15.10%-31.00%-58.91%
2024-11.61%-0.00%-15.33%-10.34%13.46%-9.75%7.98%-33.17%-1.63%-3.04%13.23%-24.94%-59.81%
20230.99%-11.15%-2.21%2.87%-8.66%-1.22%29.29%-20.13%2.36%-15.77%-9.13%-22.11%-48.68%
2022-13.43%-11.88%-0.37%-26.32%2.04%3.00%37.86%3.17%-8.53%0.75%10.74%1.00%-13.71%
202158.56%77.31%-29.38%-9.71%-21.91%-6.63%-35.17%4.41%0.33%-15.72%-25.96%-9.09%-49.64%

Benchmark Metrics

111, Inc. has an annualized alpha of -19.63%, beta of 0.75, and R2 of 0.03 versus S&P 500 Index. Calculated based on daily prices since September 12, 2018.

  • This stock participated in 163.78% of S&P 500 Index downside but only -24.43% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.03 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-19.63%
Beta
0.75
0.03
Upside Capture
-24.43%
Downside Capture
163.78%

Return for Risk

Risk / Return Rank

YI ranks 11 for risk / return — in the bottom 11% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.


YI Risk / Return Rank: 1111
Overall Rank
YI Sharpe Ratio Rank: 1515
Sharpe Ratio Rank
YI Sortino Ratio Rank: 1313
Sortino Ratio Rank
YI Omega Ratio Rank: 1414
Omega Ratio Rank
YI Calmar Ratio Rank: 1111
Calmar Ratio Rank
YI Martin Ratio Rank: 44
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for 111, Inc. (YI) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


YIBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.66

Sortino ratioReturn per unit of downside risk

-3.67

Omega ratioGain probability vs. loss probability

0.89

1.37

-0.47

Calmar ratioReturn relative to maximum drawdown

-0.80

2.78

-3.59

Martin ratioReturn relative to average drawdown

-1.59

12.44

-14.03

Dividends

Dividend History


111, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the 111, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the 111, Inc. was 99.06%, occurring on Dec 31, 2025. The portfolio has not yet recovered.

The current 111, Inc. drawdown is 98.65%.


Related event

Drawdown

Fall

Recovery

Underwater

2025 bear market2025
-99.06%Dec 2025
4y 10mo
5y 4moFeb 2021 - now
2019 bear market2019
-86.27%Sep 2019
11mo 29d1y 5mo
2y 5moSep 2018 - Feb 2021
2021 correction2021
-11.51%Feb 2021
1d4d
5dFeb 2021 - Feb 2021

Drawdown Indicators


YIBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-99.06%

-56.78%

-42.28%

Max Drawdown (1Y)

Largest decline over 1 year

-67.10%

-9.10%

-58.00%

Max Drawdown (3Y)

Largest decline over 3 years

-92.33%

-18.90%

-73.43%

Max Drawdown (5Y)

Largest decline over 5 years

-97.22%

-25.43%

-71.79%

Max Drawdown (10Y)

Largest decline over 10 years

-33.92%

Current Drawdown

Current decline from peak

-98.65%

-1.80%

-96.85%

Average Drawdown

Average peak-to-trough decline

-79.87%

-10.71%

-69.16%

Ulcer Index

Depth and duration of drawdowns from previous peaks

34.71%

2.03%

+32.68%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of 111, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how 111, Inc. is priced in the market compared to other companies in the Pharmaceutical Retailers industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for YI relative to other companies in the Pharmaceutical Retailers industry. Currently, YI has a P/S ratio of 0.0. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with YI

Add 111, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with YI